Markets & Regulations

BIO 2009: snapshot of an evolving biotech industry

BIO 2009: snapshot of an evolving biotech industry

By Nick Taylor

in-Pharmatechnologist's Nick Taylor looks back on BIO 2009, an event at which uncertainty about the development of the biotechnology industry’s future shape dominated proceedings.

France helps clusters battle for bio bucks

France helps clusters battle for bio bucks

By Nick Taylor

HEM Pierre Vimont, Ambassador of France to the US, was at BIO 2009 talking about the measures his nation have taken to attract biotechs, including the introduction of the "most favourable R&D tax in Europe".

Elan cuts jobs, shelves biofacility

Elan cuts jobs, shelves biofacility

By Phil Taylor

Faced with a tougher operating environment, Irish drugmaker Elan has decided to slash staff numbers by 230 – or around 14 per cent of its total workforce – shelve the construction of a new biologics manufacturing facility and shutter fill-and-finish capacity...

Novartis comments on $490m cell-culture vaccine contract

Novartis comments on $490m cell-culture vaccine contract

By Gareth Macdonald

Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman...

Follow us

Products

View more

Webinars